Pathogenesis of Takayasu's arteritis

Journal of Nephrology

Volumn 14, Issue 6, 2001, Pages 506-513

  Noris, Marina ^a  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

lymphocytes; Anti endothelial cell antibodies; Chemokines; Cytokines; Takayasu's arteritis

Indexed keywords

ANTIGEN; CELL ADHESION MOLECULE; CELL ANTIBODY; CHEMOKINE; CYTOKINE; FC RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 6; RANTES;

ADVENTITIA; AORTA ARCH SYNDROME; ARTERY MEDIA; AUTOIMMUNITY; CELL ACTIVATION; CELL INFILTRATION; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENDOTHELIUM CELL; GRANULOCYTE; HELPER CELL; HUMAN; HUMORAL IMMUNITY; IMMUNE COMPLEX DISEASE; IMMUNE RESPONSE; INFLAMMATORY CELL; INFLAMMATORY DISEASE; LEUKOCYTE; LYMPHOCYTIC INFILTRATION; MONOCYTE; NATURAL KILLER CELL; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; TISSUE INJURY; VASA VASORUM;

ANTIBODIES; ANTIBODY FORMATION; CHEMOKINES; CYTOKINES; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION MEDIATORS; TAKAYASU'S ARTERITIS;

EID: 0035714982     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Pathological studies on Takayasu's arteritis
2. Pathology of pulseless disease. A systematic study and critical review of twenty-one autopsy cases reported in Japan
3. Takayasu's truncoarteritis in Japan: A statistical observation of 76 autopsy cases
4. An overview on Takayasu's arteritis
5. Takayasu's arteritis and the aortic arch syndrome
6. Conference on Comparative Studies on Takayasu's arteritis among Asian Countries. Tokyo, Japan, May 16-17, 1991
7. Takayasu's arteritis. Clinical study of 107 cases
8. Takayasu's arteritis
9. Coronary arterial narrowing in Takayasu's arteritis
10. Inflammation and atherosclerosis: Atherosclerotic lesions in Takayasu's arteritis
11. Treatment of glucocorticoid-resistant or relapsing Takayasu's arteritis with methotrexate
12. Pulseless disease - A clinical analysis of 10 cases
13. Takayasu's arteritis and its therapy
14. Molecular approaches toward pathologic mechanisms in giant cell arteritis and Takayasu's arteritis
15. Association between Takayasu's arteritis and a B-cell alloantigen in North Americans
16. HLA-Bw52 in Takayasu's disease
17. HLA-linked susceptibility and resistance to Takayasu's arteritis
18. HLA typing of Takayasu's arteritis in Korea
19. Comparative studies of patients with Takayasu's arteritis in Japan, Korea and India-comparison of clinical manifestations, angiography and HLA-B antigen
20. Immunopathogenesis of Takayasu's arteritis
21. Rheumatoid spondylitis and aortic insufficiency
22. Takayasu's arteritis. Report of 5 cases with immunologic studies
23. Takayasu's arteritis. Clinical report of eighty-four cases and immunological studies of seven cases
24. Immunological studies in arteritis of aorta and great vessels
25. Accumulation of lymphocytes, dendritic cells, and granulocytes in the aortic wall affected by Takayasu's disease
26. Increased levels of soluble forms of adhesion molecules in Takayasu's arteritis
27. The functional relationship of interleukins
28. Interleukin 1 and T cell activation
29. The pathophysiologic roles of interleukin-6 in human disease
30. Cytokines, growth factors, and interferons
31. Serum myeloperoxi-dase and serum cytokines in anti-myeloperoxidase antibody-associated glomerulonephritis
32. Serum cytokine changes in systemic vasculitis
33. Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis
34. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis
35. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis
36. Restricted usage of T-cell receptor Vα-Vβ genes in infiltrating cells in aortic tissue of patients with Takayasu's arteritis
37. Interleukin-6 and RANTES in Takayasu's arteritis. A guide for therapeutic decisions?
38. Cytokines and endothelial cell biology
39. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF)
40. Leukocyte-endothelial adhesion molecules
41. IFN-β2/IL-6 augments the activity of human natural killer cells
42. B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes
43. IL-6/BSF 2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells
44. Chemokines: What chemokine is that?
45. Human chemokines: An update
46. Evidence for RANTES, monocytes chemotactic protein-1, and macrophage inflammatory protein-1b expression in Kawasaki's disease
47. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
48. C-C chemokines induce the chemotaxis of NK and IL-2 activated NK cells - Role for G proteins
49. Cytokine regulation of endothelial cell function: From molecular level to the bedside
50. Switching gears during T-cell maturation: RANTES and late transcription
51. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: Involvement of macrophages and endothelial cells
52. Serum levels of IgG, IgM and IgA immunoglobulins in nonspecific aortoarteritis in Indian population
53. Immune complexes in Takayasu's arteritis
54. Identification of an autoantibody to vascular endothelial cell-specific antigens in patients with systemic vasculitis
55. Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis
56. Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis
57. Immunoglobulin M antibodies present in the acute phase of Kawasaki's syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon
58. Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis
59. Autoantibodies in cardiovascular disease
60. Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS
61. Nonspecific aortoarteritis (Takayasu's disease): An immunologic and autopsy study
62. Anti-endothelial cell antibodies in Takayasu's arteritis
63. Autoantibodies in vasculitis: Current perspectives
64. Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells
65. IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro
66. A bias in the alphabeta T cell receptor variable region gene usage in Takayasu's arteritis
67. Current status of Takayasu's arteritis in India
68. Role of calcium and protein kinase C in the activation of T cells in Takayasu's arteritis
69. Takayasu's arteritis: A pathogenetic role for cytotoxic T lymphocytes?
70. Pathogenesis of vasculitis syndromes
71. Wegener's granulomatosis: An analysis of 158 patients
72. Perforin-secreting killer cell infiltration and expression of a 65-kD heat-shock protein in aortic tissue of patients with Takayasu's arteritis
73. Killing of target cells by lymphocytes: A mechanistic view
74. Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity
75. Properties of a purified pore-forming protein (perforin 1) isolated from H-2 restricted cytotoxic T cell granules
76. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells
77. Mycophenolate mofetil for the treatment of Takayasu's arteritis: Report of three cases